Treatment prospects for autosomal-dominant polycystic kidney disease

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Treatment prospects for autosomal-dominant polycystic kidney disease. An increased understanding of the molecular genetic and cellular pathophysiologic mechanisms responsible for the development of autosomal-dominant polycystic kidney disease (ADPKD), made possible by the advances in molecular biology and genetics of the last three decades, has laid the foundation for the development of effective therapies. As the concept that a polycystic kidney is a neoplasm in disguise is becoming increasingly accepted, the development of therapies for ADPKD may benefit greatly from the expanding body of information on cancer chemoprevention and chemosuppression. This review summarizes the observations that already have been made and discusses therapies for PKD that deserve investigation.

Original languageEnglish (US)
Pages (from-to)2005-2022
Number of pages18
JournalKidney International
Volume59
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Autosomal Dominant Polycystic Kidney
Molecular Biology
Polycystic Kidney Diseases
Chemoprevention
Therapeutics
Neoplasms

Keywords

  • Antimutagens
  • Antioxidants
  • EGF receptor
  • Fish oil
  • Soy protein
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Nephrology

Cite this

Treatment prospects for autosomal-dominant polycystic kidney disease. / Qian, Qi; Harris, Peter C; Torres, Vicente.

In: Kidney International, Vol. 59, No. 6, 2001, p. 2005-2022.

Research output: Contribution to journalArticle

@article{9f0b3bb899144e7d82dc400e7b34b068,
title = "Treatment prospects for autosomal-dominant polycystic kidney disease",
abstract = "Treatment prospects for autosomal-dominant polycystic kidney disease. An increased understanding of the molecular genetic and cellular pathophysiologic mechanisms responsible for the development of autosomal-dominant polycystic kidney disease (ADPKD), made possible by the advances in molecular biology and genetics of the last three decades, has laid the foundation for the development of effective therapies. As the concept that a polycystic kidney is a neoplasm in disguise is becoming increasingly accepted, the development of therapies for ADPKD may benefit greatly from the expanding body of information on cancer chemoprevention and chemosuppression. This review summarizes the observations that already have been made and discusses therapies for PKD that deserve investigation.",
keywords = "Antimutagens, Antioxidants, EGF receptor, Fish oil, Soy protein, Tyrosine kinase inhibitors",
author = "Qi Qian and Harris, {Peter C} and Vicente Torres",
year = "2001",
doi = "10.1046/j.1523-1755.2001.0590062005.x",
language = "English (US)",
volume = "59",
pages = "2005--2022",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Treatment prospects for autosomal-dominant polycystic kidney disease

AU - Qian, Qi

AU - Harris, Peter C

AU - Torres, Vicente

PY - 2001

Y1 - 2001

N2 - Treatment prospects for autosomal-dominant polycystic kidney disease. An increased understanding of the molecular genetic and cellular pathophysiologic mechanisms responsible for the development of autosomal-dominant polycystic kidney disease (ADPKD), made possible by the advances in molecular biology and genetics of the last three decades, has laid the foundation for the development of effective therapies. As the concept that a polycystic kidney is a neoplasm in disguise is becoming increasingly accepted, the development of therapies for ADPKD may benefit greatly from the expanding body of information on cancer chemoprevention and chemosuppression. This review summarizes the observations that already have been made and discusses therapies for PKD that deserve investigation.

AB - Treatment prospects for autosomal-dominant polycystic kidney disease. An increased understanding of the molecular genetic and cellular pathophysiologic mechanisms responsible for the development of autosomal-dominant polycystic kidney disease (ADPKD), made possible by the advances in molecular biology and genetics of the last three decades, has laid the foundation for the development of effective therapies. As the concept that a polycystic kidney is a neoplasm in disguise is becoming increasingly accepted, the development of therapies for ADPKD may benefit greatly from the expanding body of information on cancer chemoprevention and chemosuppression. This review summarizes the observations that already have been made and discusses therapies for PKD that deserve investigation.

KW - Antimutagens

KW - Antioxidants

KW - EGF receptor

KW - Fish oil

KW - Soy protein

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=0034999513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034999513&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2001.0590062005.x

DO - 10.1046/j.1523-1755.2001.0590062005.x

M3 - Article

C2 - 11380803

AN - SCOPUS:0034999513

VL - 59

SP - 2005

EP - 2022

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 6

ER -